Johnson & Johnson Vaccine is 66% Effective in Preventing Moderate To Severe COVID-19

The COVID-19 vaccination was studied in 44,000 people and was found to prevent COVID in 72% in the US, 66% in Latin America, and 57% in South Africa. These findings in South Africa give some pause since this variant strain has now made its way to the US.
Read More…